Copyright
©The Author(s) 2022.
World J Clin Cases. Apr 26, 2022; 10(12): 3936-3943
Published online Apr 26, 2022. doi: 10.12998/wjcc.v10.i12.3936
Published online Apr 26, 2022. doi: 10.12998/wjcc.v10.i12.3936
Observation time | Complaint | Cardiac injury markers | Main diagnosis | Culprit vessel | Antithrombotic agents |
0 mo | Chest pain | Positive | STEMI | Thrombus in RCA | Aspirin (100 mg 1/d), clopidogrel (75 mg 1/d), LMWH for 1 wk |
1 mo | None | Decreased | CHD | No obvious thrombosis in RCA | Aspirin (100 mg 1/d), clopidogrel (75 mg 1/d) |
5 mo | Chest pain | Positive | STEMI | 100% occluded, thrombus in RCA | Aspirin (100 mg 1/d), clopidogrel (75 mg 1/d), LMWH for 1 wk |
6 mo | chest tightness | Negative | UAP | Middle of RCA was slightly blurred | Aspirin (100 mg 1/d), ticagrelor (90 mg 2/d) |
18 mo | None | Negative | CHD | - | Aspirin (100 mg 1/day), ticagrelor (45 mg 2/d) |
48 mo | None | Negative | CHD | - | Aspirin (100 mg 1/d), ticagrelor (90 mg 2/d) |
- Citation: Liu RF, Gao XY, Liang SW, Zhao HQ. Antithrombotic treatment strategy for patients with coronary artery ectasia and acute myocardial infarction: A case report. World J Clin Cases 2022; 10(12): 3936-3943
- URL: https://www.wjgnet.com/2307-8960/full/v10/i12/3936.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i12.3936